ENT features archive for November 2022
The integration of targeted therapy and surgery in advanced thyroid cancer clinical trials
One of the headline speakers, Mark Zafereo, will be talking at IFOS about thyroid cancer. We hear from his team about some of the areas they will be discussing. Locally advanced thyroid cancer generally refers to patients who have significant...
Hearing implant devices: new expectations during IFOS 2023 ENT World Congress, Dubai
We hear from one of the senior members of the IFOS Executive Board about the aspects of IFOS that he is looking forward to – and, in particular, his focus on implantable hearing devices. From 17 to 21 January 2023,...
Olfaction in CRS
Conventional teaching tells us that hyposmia in chronic rhinosinusitis is due to mechanical obstruction of the olfactory cleft. But it might be that the story is slightly more complicated than that. Olfactory dysfunction is a common feature of chronic rhinosinusitis...
IFOS 2026 bid cities
As Dubai prepares to host IFOS 2023, the next IFOS congress in 2026 is already being planned. The competition to host the meeting is certain to be fierce – we hear from the organisers around the world bidding to bring...
Otolaryngologists and audiologists are invited to learn about and lead efforts to reduce the global burden of hearing loss
IFOS promises to be a multidimensional meeting, with contributions from speakers from all corners of the world covering a huge array of subjects. We hear about how the global health aspects of hearing loss will be covered in the congress....
